vs

Side-by-side financial comparison of ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

ESSENTIAL PROPERTIES REALTY TRUST, INC. is the larger business by last-quarter revenue ($158.8M vs $127.1M, roughly 1.2× Zai Lab Ltd). On growth, ESSENTIAL PROPERTIES REALTY TRUST, INC. posted the faster year-over-year revenue change (22.8% vs 17.1%). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 20.6%).

Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

EPRT vs ZLAB — Head-to-Head

Bigger by revenue
EPRT
EPRT
1.2× larger
EPRT
$158.8M
$127.1M
ZLAB
Growing faster (revenue YoY)
EPRT
EPRT
+5.6% gap
EPRT
22.8%
17.1%
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
20.6%
EPRT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EPRT
EPRT
ZLAB
ZLAB
Revenue
$158.8M
$127.1M
Net Profit
$60.0M
Gross Margin
51.0%
Operating Margin
56.5%
-54.6%
Net Margin
37.8%
Revenue YoY
22.8%
17.1%
Net Profit YoY
6.5%
EPS (diluted)
$0.28
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPRT
EPRT
ZLAB
ZLAB
Q1 26
$158.8M
Q4 25
$149.9M
$127.1M
Q3 25
$144.9M
$115.4M
Q2 25
$137.1M
$109.1M
Q1 25
$129.4M
$105.7M
Q4 24
$119.7M
$108.5M
Q3 24
$117.1M
$101.8M
Q2 24
$109.3M
$100.1M
Net Profit
EPRT
EPRT
ZLAB
ZLAB
Q1 26
$60.0M
Q4 25
$68.1M
Q3 25
$65.6M
$-36.0M
Q2 25
$63.2M
$-40.7M
Q1 25
$56.1M
$-48.4M
Q4 24
$55.4M
Q3 24
$49.1M
$-41.7M
Q2 24
$51.5M
$-80.3M
Gross Margin
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Operating Margin
EPRT
EPRT
ZLAB
ZLAB
Q1 26
56.5%
Q4 25
65.9%
-54.6%
Q3 25
64.7%
-42.3%
Q2 25
64.1%
-50.3%
Q1 25
61.6%
-53.3%
Q4 24
66.1%
-62.6%
Q3 24
59.7%
-66.6%
Q2 24
61.1%
-76.0%
Net Margin
EPRT
EPRT
ZLAB
ZLAB
Q1 26
37.8%
Q4 25
45.4%
Q3 25
45.3%
-31.2%
Q2 25
46.1%
-37.3%
Q1 25
43.4%
-45.8%
Q4 24
46.3%
Q3 24
42.0%
-40.9%
Q2 24
47.1%
-80.2%
EPS (diluted)
EPRT
EPRT
ZLAB
ZLAB
Q1 26
$0.28
Q4 25
$0.34
$-0.05
Q3 25
$0.33
$-0.03
Q2 25
$0.32
$-0.04
Q1 25
$0.29
$-0.04
Q4 24
$0.31
$-0.09
Q3 24
$0.27
$-0.04
Q2 24
$0.29
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPRT
EPRT
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$15.2M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.4B
$715.5M
Total Assets
$7.2B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPRT
EPRT
ZLAB
ZLAB
Q1 26
$15.2M
Q4 25
$60.2M
$689.6M
Q3 25
$23.8M
$717.2M
Q2 25
$20.8M
$732.2M
Q1 25
$47.0M
$757.3M
Q4 24
$40.7M
$779.7M
Q3 24
$32.7M
$616.1M
Q2 24
$23.6M
$630.0M
Total Debt
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
$2.5B
Q3 25
$2.6B
Q2 25
$2.3B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.2B
Q2 24
$1.9B
Stockholders' Equity
EPRT
EPRT
ZLAB
ZLAB
Q1 26
$4.4B
Q4 25
$4.2B
$715.5M
Q3 25
$3.8B
$759.9M
Q2 25
$3.8B
$791.7M
Q1 25
$3.8B
$810.8M
Q4 24
$3.6B
$840.9M
Q3 24
$3.2B
$667.7M
Q2 24
$3.2B
$704.2M
Total Assets
EPRT
EPRT
ZLAB
ZLAB
Q1 26
$7.2B
Q4 25
$6.9B
$1.2B
Q3 25
$6.6B
$1.2B
Q2 25
$6.3B
$1.2B
Q1 25
$6.1B
$1.2B
Q4 24
$5.8B
$1.2B
Q3 24
$5.5B
$985.3M
Q2 24
$5.3B
$987.4M
Debt / Equity
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
0.60×
Q3 25
0.69×
Q2 25
0.61×
Q1 25
0.56×
Q4 24
0.60×
Q3 24
0.69×
Q2 24
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPRT
EPRT
ZLAB
ZLAB
Operating Cash FlowLast quarter
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
$381.1M
$-26.0M
Q3 25
$99.0M
$-32.0M
Q2 25
$99.8M
$-31.0M
Q1 25
$77.2M
$-61.7M
Q4 24
$308.5M
$-55.8M
Q3 24
$73.5M
$-26.8M
Q2 24
$81.1M
$-42.2M
Free Cash Flow
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-63.2M
Q4 24
$-58.4M
Q3 24
$-28.2M
Q2 24
$-42.9M
FCF Margin
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-59.9%
Q4 24
-53.8%
Q3 24
-27.7%
Q2 24
-42.9%
Capex Intensity
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.5%
Q4 24
2.4%
Q3 24
1.3%
Q2 24
0.7%
Cash Conversion
EPRT
EPRT
ZLAB
ZLAB
Q1 26
Q4 25
5.60×
Q3 25
1.51×
Q2 25
1.58×
Q1 25
1.38×
Q4 24
5.57×
Q3 24
1.50×
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPRT
EPRT

Rental revenue 1,2$149.4M94%
Other$8.6M5%
Other revenue$779.0K0%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons